Celularity (CELU) - 2021 Q2 - Quarterly Report
Celularity (CELU)2021-08-19 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38914 CELULARITY INC. (Exact Name of Registrant as Specified in Its Charter) | --- | --- | --- | |------------------------------------|----- ...